Investor News

Orbia Announces Conference Call For Its Fourth Quarter and Full Year 2025 Earnings Results

Mexico City, January 9, 2025 – Orbia will release its fourth quarter 2025 earnings results after the market closes on Tuesday, February 24, 2026. On Wednesday, February 25, 2026, Management will host a conference call and Q&A session to review the Q4 and full year 2025 results. Read more...

Orbia Reports on Fitch Credit Ratings Update

Mexico City, October 29, 2025 – Orbia informs that Fitch Ratings has modified OrbIa’s credit ratings as follows: Long term Foreign and Local Currency Issuer Default Rating (IDR): From BBB to BBB-; Senior Unsecured Notes: From BBB to BBB-; National Scale Long Term Rating: From AAA to AA+; Local bond issuances: From AAA to AA+. The outlook for these ratings is stable and remains within the Investment Grade category. Read more...

Orbia Announces Third Quarter 2025 Financial Results

Mexico City, October 22, 2025 – Today Orbia released unaudited results for the third quarter of 2025. Orbia delivered revenues of $1.97 billion and EBITDA of $295 million for the quarter. Operating cash flow of $271 million represented a conversion rate of 92% of EBITDA for the third quarter of 2025. Read more...

MORE PRESS RELEASES

Preview Square.png

How Orbia Plans to Decarbonize Inhalers for 100 Million Patients Each Year, Accelerating the Pharma Industry’s Sustainability Transition

January 12, 2026 – Thirty years ago, Orbia’s Fluor & Energy Materials business introduced the most widely used propellant in inhalers: Zephex 134a. Today, it is used in two thirds of all inhalers, enabling 100 million patients to access their lifesaving medicine each year. Even as Zephex 134a became the global standard, the team launched R&D to develop a more climate-friendly solution. After 10 years of development, Zephex 152a was created, which has a 90% less global warming potential than Zephex 134a. Orbia’s latest Megatrendsetters article explores how we’re leading the shift to greener inhalers—combining scientific innovation with environmental responsibility.

Orbia Honored as a Top Company in its Industry in the S&P Global Sustainability Yearbook for Fifth Consecutive Year

February 19, 2025 – Orbia has been named a member of the S&P Global Sustainability Yearbook for the fifth consecutive year. S&P Global Sustainability Yearbook members are the top performing companies within their industry. Orbia scored within the top 15% of companies in the chemicals category. In 2025, more than 9,200 companies were assessed with less than 10% selected for the 2026 Yearbook inclusion.Read more...

Orbia Fluor & Energy Materials Completes Expansion of Custom Electrolyte Facility

December 16, 2025 – Orbia's Fluor & Energy Materials business today announced it has completed the expansion of its Custom Electrolyte facility for lithium-ion and other battery chemistries in Madison, Wisconsin, increasing the site production capacity by roughly 300%. The facility enables domestic sourcing of small and medium batch battery electrolytes in the United States, tailored to exact specifications for lithium-ion as well as emerging chemistries such as lithium-sulfur, sodium-ion and beyond. Read more...

Orbia CEO Interview: Leading Through Volatility While Positioning Orbia for Growth

December 11, 2025 – In a recent interview with MIT Sloan Management Review, Orbia CEO Sameer Bharadwaj shared his perspective on leading Orbia through one of the most volatile macroeconomic climates in the company’s history. Throughout the conversation, Bharadwaj highlighted priorities and long-term enablers anchoring Orbia’s business strategy including operational discipline and cost optimization, a long-term focus supported by a controlling shareholder and innovation in essential sustainable materials and solutions that will drive future growth. Read more...